Feb 8 (Reuters) - Anteris Technologies:
* CO HAS RECEIVED A CONFIDENTIAL, NON-BINDING PROPOSAL TO
NEGOTIATE A LETTER OF INTENT
* BOARD IS CONSIDERING PROPOSAL
* LETTER SETS OUT PROPOSAL TO MERGE WITH NASDAQ-LISTED
MEDICUS
SCIENCES ACQUISITION CORP
* PROPOSAL CONTEMPLATES AN ISSUANCE OF NEW EQUITY BY MSAC IN
EXCHANGE FOR CURRENT SHARES IN CO
* ISSUANCE OF NEW EQUITY AT EQUIVALENT VALUE & STIPULATES
THAT
POST-TRANSACTION MERGED ENTITY TO HAVE A MINIMUM OF $US50M IN
CASH
* PROPOSAL STIPULATES THAT POST-TRANSACTION MERGED ENTITY
WOULD
HAVE MINIMUM OF $US50M IN CASH,PLUS EXISTING FUNDS HELD BY CO
* THERE IS NO CERTAINTY THAT CO WILL PROCEED WITH PROPOSAL &
PROPOSAL WILL RESULT IN ANY TRANSACTION OCCURRING
Source text for Eikon: ID:nASXb41V77
Further company coverage: AVR.AX
((Reuters.Briefs@thomsonreuters.com;))